Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-year lung function decline in sarcoidosis.

Respiratory investigation·2023
Same author

Lung function decline in sarcoidosis.

Respiratory investigation·2022
Same author

Basal interventricular septum thinning and long-term left ventricular function in patients with sarcoidosis.

Respiratory investigation·2022
Same author

The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study.

Respiratory medicine·2021
Same author

Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis.

Communications biology·2020
Same author

Can the Sarcoidosis Health Questionnaire predict the long-term outcomes in Japanese sarcoidosis patients?

Respiratory medicine·2019

Related Experiment Videos

[Interstitial pneumonia--diagnosis and therapy].

Sonoko Nagai1

  • 1Central Clinic, Research Center, Sanjo-Takakura, Nakagyou-ku, Kyoto, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|July 18, 2008
PubMed
Summary

Interstitial pneumonia involves fibrotic lung disease leading to respiratory failure. This review covers its types, diagnosis, prognosis, and treatment challenges, focusing on idiopathic pulmonary fibrosis.

Area of Science:

  • Pulmonology
  • Pathology
  • Fibrotic Lung Diseases

Context:

  • Interstitial pneumonia is a group of fibrotic lung diseases affecting the alveolar interstitium.
  • Idiopathic interstitial pneumonia encompasses seven distinct clinico-radiological-pathological entities.
  • Idiopathic pulmonary fibrosis (IPF), characterized by usual interstitial pneumonia (UIP) histology, has a poor prognosis.

Purpose:

  • To review the spectrum of interstitial pneumonia.
  • To discuss classification, differential diagnosis, and prognosis.
  • To examine therapeutic challenges in managing these fibrotic lung diseases.

Summary:

  • Interstitial pneumonia is characterized by fibrosis in the alveolar interstitium, potentially leading to respiratory failure.
  • Idiopathic pulmonary fibrosis (IPF) exhibits usual interstitial pneumonia (UIP) histology and a worse prognosis compared to other types.

Related Experiment Videos

  • UIP histology may indicate a better prognosis when associated with collagen vascular diseases.

    • Impact:

    • Provides a comprehensive overview of interstitial pneumonia for clinicians and researchers.
    • Highlights the prognostic differences between IPF/UIP and other interstitial lung diseases.
    • Identifies key areas for future therapeutic development in fibrotic lung disease management.